These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28115082)

  • 1. The ESRD Quality Incentive Program: The Current Limitations of Evidence and Data to Develop Measures, Drive Improvement, and Incentivize Outcomes.
    Diamond LH; Howard AD
    Adv Chronic Kidney Dis; 2016 Nov; 23(6):377-384. PubMed ID: 28115082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do current quality measures truly reflect the quality of dialysis?
    Gupta N; Wish JB
    Semin Dial; 2018 Jul; 31(4):406-414. PubMed ID: 29482262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the ESRD quality incentive program could potentially improve quality of life for patients on dialysis.
    Moss AH; Davison SN
    Clin J Am Soc Nephrol; 2015 May; 10(5):888-93. PubMed ID: 25739850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes to the end-stage renal disease quality incentive program.
    Fishbane S; Miller I; Wagner JD; Masani NN
    Kidney Int; 2012 Jun; 81(12):1167-71. PubMed ID: 22534963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.
    Ajmal F; Probst JC; Brooks JM; Hardin JW; Qureshi Z; Jafar TH
    Am J Kidney Dis; 2020 Feb; 75(2):177-186. PubMed ID: 31685294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ESRD Quality Incentive Program-Can We Bridge the Chasm?
    Weiner D; Watnick S
    J Am Soc Nephrol; 2017 Jun; 28(6):1697-1706. PubMed ID: 28298324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program.
    Breck A; Marr J; Turenne M; Esposito D
    Med Care; 2022 Oct; 60(10):735-742. PubMed ID: 35880769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The QIP: will it improve dialysis care? An overview.
    Fishbane S; Miller I; Danko H; Masani N
    Nephrol News Issues; 2012 Jan; 26(1):20, 22-4, 26. PubMed ID: 22359961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers.
    Fishbane S; Hazzan A
    Am J Kidney Dis; 2012 Nov; 60(5 Suppl 1):S5-13; quiz S14-7. PubMed ID: 23063058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESRD Networks: past, present, and challenges for the future.
    Wish JB; Meyer KB
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1907-14. PubMed ID: 22977212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical director and quality requirements in the dialysis facility.
    Schiller B
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):493-9. PubMed ID: 25376762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality Risk of Patients Treated in Dialysis Facilities with Payment Reductions under ESRD Quality Incentive Program.
    Griffin SM; Marr J; Kapke A; Jin Y; Pearson J; Esposito D; Young EW
    Clin J Am Soc Nephrol; 2023 Mar; 18(3):356-362. PubMed ID: 36763812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early winners and losers in dialysis center pay-for-performance.
    Saunders MR; Lee H; Chin MH
    BMC Health Serv Res; 2017 Dec; 17(1):816. PubMed ID: 29216894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring, managing, and improving the quality of end-stage renal disease care.
    Levinsky NG; Mesler DE
    Am J Kidney Dis; 1994 Aug; 24(2):235-46. PubMed ID: 8048431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.
    Piri S
    Eur J Health Econ; 2024 Mar; 25(2):221-236. PubMed ID: 36966480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guiding principles and checklist for population-based quality metrics.
    Krishnan M; Brunelli SM; Maddux FW; Parker TF; Johnson D; Nissenson AR; Collins A; Lacson E
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1124-31. PubMed ID: 24558050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data management to understand outcomes and trends in ESRD.
    Wish JB
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S165-72. PubMed ID: 9892386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.